{"entity":{"type":"insider","cik":"0001776024","url":"/insider/0001776024","json_url":"/insider/0001776024.json","name":"Faulkingham Dell","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2020-06-02","last":"2022-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Faulkingham Dell","source":"filing","n_filings":4,"first_seen":"2020-06-02","last_seen":"2022-03-02"}],"transactions":[{"id":6971241,"accession":"0001562180-22-002162","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-22-002162","line_url":"/filing/0001562180-22-002162","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001776024","owner_name":"Faulkingham Dell","owner_display_name":"Faulkingham Dell","owner_url":"/insider/0001776024","role":"Officer (SVP, CCO)","role_mark":"O","role_mark_label":"Officer (SVP, CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6705.0,"shares_display":"6,705","price_per_share":2.1707,"price_display":"2.17","price_state":"stated","total_value":14554.5435,"total_display":"14,554.54","total_whole":"14,555","shares_owned_after":174798.0,"shares_owned_after_display":"174,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-02","scope":"insider","n_lines":2},{"id":6971234,"accession":"0001562180-22-002162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-002162","line_url":"/filing/0001562180-22-002162#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001776024","owner_name":"Faulkingham Dell","owner_display_name":"Faulkingham Dell","owner_url":"/insider/0001776024","role":"Officer (SVP, CCO)","role_mark":"O","role_mark_label":"Officer (SVP, CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6479.0,"shares_display":"6,479","price_per_share":2.1548,"price_display":"2.15","price_state":"stated","total_value":13960.9492,"total_display":"13,960.95","total_whole":"13,961","shares_owned_after":130546.0,"shares_owned_after_display":"130,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider"},{"id":5324984,"accession":"0001562180-21-002544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-002544","line_url":"/filing/0001562180-21-002544#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001776024","owner_name":"Faulkingham Dell","owner_display_name":"Faulkingham Dell","owner_url":"/insider/0001776024","role":"Officer (SVP, CCO)","role_mark":"O","role_mark_label":"Officer (SVP, CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":952.0,"shares_display":"952","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":3236.8,"total_display":"3,236.80","total_whole":"3,237","shares_owned_after":137025.0,"shares_owned_after_display":"137,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-01","scope":"insider"},{"id":5376079,"accession":"0001562180-21-001786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-001786","line_url":"/filing/0001562180-21-001786#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001776024","owner_name":"Faulkingham Dell","owner_display_name":"Faulkingham Dell","owner_url":"/insider/0001776024","role":"Officer (CCO)","role_mark":"O","role_mark_label":"Officer (CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6749.0,"shares_display":"6,749","price_per_share":3.3961,"price_display":"3.40","price_state":"stated","total_value":22920.2789,"total_display":"22,920.28","total_whole":"22,920","shares_owned_after":128825.0,"shares_owned_after_display":"128,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":2316459,"accession":"0001562180-20-004068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-004068","line_url":"/filing/0001562180-20-004068#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001776024","owner_name":"Faulkingham Dell","owner_display_name":"Faulkingham Dell","owner_url":"/insider/0001776024","role":"Officer (CCO)","role_mark":"O","role_mark_label":"Officer (CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6426.0,"shares_display":"6,426","price_per_share":11.58,"price_display":"11.58","price_state":"stated","total_value":74413.08,"total_display":"74,413.08","total_whole":"74,413","shares_owned_after":73574.0,"shares_owned_after_display":"73,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001517022","name":"Akebia Therapeutics, Inc.","url":"/issuer/0001517022","role":"Officer (SVP, CCO)","n_filings":4,"first_seen":"2020-06-02","last_seen":"2022-03-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001776024","retrieved_at":"2026-08-24T15:28:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}